This company webcast features ChromaDex Corp. (Nasdaq: CDXC). ChromaDex is the global authority on nicotinamide adenine dinucleotide (NAD+), with a focus on the science of healthy aging.

This company webcast was recorded during the Lytham Partners 2025 Investor Healthcare Summit.